NOVARTIS AG (NVSEF)
Clinical trial NCT07604324 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-25 → 2026-06-02 3. enrollment: not set → 63 participants
Clinical trial NCT07604324 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-25 → 2026-06-02 3. enrollment: not set → 63 participants
Clinical trial NCT04221542: enrollment: not set → 479 participants.
Clinical trial NCT06910813: enrollment: not set → 30 participants.
Clinical trial NCT06963827: enrollment: not set → 347 participants.
Clinical trial NCT05811416 updates: 1. completion date: 2026-11-09 → 2027-01-20 2. primary completion date: 2026-11-09 → 2027-01-20 3. enrollment: not set → 200 participants
Clinical trial NCT06700343: enrollment: not set → 444 participants.
Clinical trial NCT05843253: enrollment: not set → 120 participants.
Clinical trial NCT04983030 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-30 → 2026-02-23 3. primary completion date: 2026-02-28 → 2026-02-23 4. enrollment: not set → 28 participants
Clinical trial NCT06948435 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 487 participants
Clinical trial NCT07543055 updates: 1. start date: 2026-05-14 → 2026-06-01 2. completion date: 2030-11-04 → 2031-03-20 3. primary completion date: 2029-12-13 → 2029-12-31 4. enrollment: not set → 36 participants